In a study of 125 primary non-small cell lung cancer compared to benign pulmonary lesions, high IGF-I and IGF-IR levels were associated with advanced-stage disease and expression of IGF-I correlated with tumor size and poor outcome [27]. The gene discussed is IGF1; the disease is neoplasm.